Skip to main content
. 2025 Sep 13;18:5491–5501. doi: 10.2147/IJGM.S544396

Table 3.

Contrast Nephropathy Associated with Chronic Disease and Medications

Chronic disease, n (%) Contrast Nephropathy p-value
Yes
n=65
No
n=317
Hypertension
Yes
No
0.001
40 (24.4) 124 (75.6)
25 (11.5) 193 (88.5)
Chronic kidney disease
Yes
No
0.066
7 (33.3) 14 (66.7)
58 (16.10) 303 (83.9)
Type 2 Diabetes
Yes
No
0.034
25 (23.6) 81 (76.4)
40 (14.5) 236 (85.5)
Atrial Fibrilation
Yes
No
1,000
3(23.6) 14 (82.4)
62 (17) 303 (83)
Hyperlipidemia
Yes
No
0.013
10 (33.3) 20 (66.7)
55 (15.6) 297 (84.4)
COPD1
Yes
No
0.416
6 (23.1) 20 (76.9)
59 (16.6) 297 (83.4)
Congestive Heart Failure
Yes
No
0.011
22 (26.2) 62 (73.8)
43 (14.4) 255 (85.6)
Medications n (%)
ARB2
Yes
No
0.292
7 (25) 21 (75)
58 (16.4) 296 (83.6)
Statins
Yes
No
0.023
9 (36) 16 (64)
56 (15.7) 301 (84.3)
NSAIDs3
Yes
No
0.785
6 (18.8) 26 (81.3)
59 (16.9) 291 (83.1)
Diuretics
Yes
No
0.005
23 (17.1) 62 (72.9)
42 (14.1) 255 (85.9)
ACEI4
Yes
No
0.668
22 (26.2) 62 (73.8)
54 (16.7) 270 (83.3)

Notes: Values are presented as n (%). Italicised values indicate statistically significant differences (p < 0.05).

Abbreviations: COPD1, Chronic Obstructive Pulmonary Disease; ARB2, Angiotensin Receptor Blocker; NSAIDs3; non-steroidal anti-inflammatory drug; ACEI4, Angiotensin- Converting Enzyme Inhibitor.